GlaxoSmithKline Consumer Healthcare informs about board meeting

03 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, GlaxoSmithKline Consumer Healthcare has informed that the Board of Directors of the Company in its meeting held on December 03, 2018, has considered and approved a scheme of amalgamation between the Company and Hindustan Unilever Limited (HUL), and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The Scheme is subject to necessary statutory and regulatory approvals under applicable laws, including by BSE and National Stock Exchange of India, SEBI, Competition Commission of India, the National Company Law Tribunal, and the respective shareholders and creditors of the Company and HUL.

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 2483.80
Britannia Inds 4797.55
Varun Beverages 1457.80
Marico 517.70
Hatsun Agro Product 1102.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.